Pregnancy

Women With Myeloproliferative Neoplasms Appear to Have Successful Pregnancies

Women With Myeloproliferative Neoplasms Appear to Have Successful Pregnancies

Evidence suggests that women with myeloproliferative neoplasms have a higher risk of maternal and fetal complications. In this data analysis, researchers evaluated outcomes for pregnant women with essential thrombocythemia, polycythemia, or myelofibrosis and their infants.

Pregnancy Screening Inconsistent in Female Adolescents Before Chemotherapy Exposure

Pregnancy Screening Inconsistent in Female Adolescents Before Chemotherapy Exposure

By

Pregnancy screening rates before teratogenic exposures are low for female adolescent patients with acute leukemia and those with ER visits including abdominal/pelvic CT.

<i>BRCA1</i> Mutation May Reduce Women's Fertility

BRCA1 Mutation May Reduce Women's Fertility

The BRCA1 mutation may speed the aging of a woman's ovaries,according to a recent report.

Prognosis Poor for Women With Pregnancy-Associated Melanoma

Prognosis Poor for Women With Pregnancy-Associated Melanoma

Among women aged up to 49 years with a pregnancy-associated melanoma, recurrence rates were higher than seen in other groups.

Prognosis Is Poor for Women With Pregnancy-Associated Melanoma

Prognosis Is Poor for Women With Pregnancy-Associated Melanoma

By

A recent study showed that women younger than 50 years who are pregnant or were recently pregnant at diagnosis of melanoma have a higher risk of death from the skin cancer.

Impact of Prenatal Exposure to Maternal Cancer Investigated

Impact of Prenatal Exposure to Maternal Cancer Investigated

Prenatal exposure to maternal cancer, with or without treatment, does not appear to impact early child development, a study found.

Pregnancy should not delay cancer treatment, study suggests

Pregnancy should not delay cancer treatment, study suggests

Women whose cancer is diagnosed while pregnant can start cancer treatment immediately and do not need to terminate the pregnancy.

Cancer risk linked to incidence of intrahepatic cholestasis of pregnancy

By

The risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is increased in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.

Prenatal genetic tests useful for identification of maternal cancers

Prenatal genetic tests useful for identification of maternal cancers

Abnormal findings on early test don't always indicate birth defects, researchers say, but could instead indicate cancer.

Embryo cryopreservation possible for women with breast cancer

Embryo cryopreservation possible for women with breast cancer

Embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility for patients with breast cancer, according to a study published online.

In mothers, non-invasive prenatal fetal testing can detect early cancer

In mothers, non-invasive prenatal fetal testing can detect early cancer

Non-invasive prenatal testing (NIPT) can be employed as a less-invasive means to detect cancer in expecting mothers.

Psychosocial challenges of pregnancy-associated breast cancer (PABC)

Psychosocial challenges of pregnancy-associated breast cancer (PABC)

By

Breast cancer during pregnancy presents additional psychosocial challenges as patients cope with a devastating diagnosis during a time of hope and promise for the future.

Pregnancy-related risks impact childbearing decisions for meningioma survivors

By

Female meningioma survivors are more likely to want and to become pregnant than the general population, and some research indicates that pregnancy may be a risk factor for tumor progression or recurrence.

Mortality rates not increased in pregnancy-associated malignant melanoma

Mortality rates not increased in pregnancy-associated malignant melanoma

Cause-specific mortality similar for women and girls with pregnancy-associated MM or non-PAMM.

Oral Contraceptives and Cancer Risk (Fact Sheet)

Oral Contraceptives and Cancer Risk (Fact Sheet)

This fact sheet examines the relationship between oral contraception and risk of breast, ovarian, endometrial, liver, and cervical cancers.

International team assessed the impact of cancer treatment on children of women pregnant at diagnosis or during treatment

By

A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.

ESHRE: Low evidence of fertility drug and cancer link

ESHRE: Low evidence of fertility drug and cancer link

Use of fertility drugs doesn't appear to increase a woman's long-term risk of breast, ovarian, and uterine cancers, new research indicates, but researchers still urge long-term monitoring.

IUDs may up breast cancer risk

IUDs may up breast cancer risk

A new study has found that the levonorgestrel-releasing intrauterine system, or progesterone-releasing IUD, may be associated with a higher than expected incidence of breast cancer.

Smoking and smoke exposure increase adverse pregnancy outcomes

Smoking and smoke exposure increase adverse pregnancy outcomes

Increased odds for spontaneous abortions, stillbirths, and ectopic pregnancies were seen for smokers, compared to never-smoking women.

Young women with breast cancer often have fertility concerns

Young women with breast cancer often have fertility concerns

Fertility concerns are common among young women with newly diagnosed breast cancer, although only a minority pursue fertility preservation strategies.

Maternal coffee consumption tied to childhood leukemia

Maternal coffee consumption tied to childhood leukemia

Linear dose-response relationship for acute lymphoblastic leukemia and acute myeloid leukemia has been observed.

Oral contraceptives not linked to breast or ovarian cancer

Oral contraceptives not linked to breast or ovarian cancer

Risk the same as found in women in the general population with regard to oral contraceptive use.

Study findings reveal key characteristics of meningiomas during pregnancy

Hemodynamic changes associated with pregnancy explain the growth of benign tumors in pregnant women. The study also identified some key characteristics associated with rapid growth of meningiomas in pregnant women.

Chemo for Breast Cancer Acceptable During Pregnancy

Chemo for Breast Cancer Acceptable During Pregnancy

Adverse events more common for infants exposed to chemo in utero; mainly due to premature birth.

Gender gap in reproductive preservation in cancer patients

Gender gap in reproductive preservation in cancer patients

Men report routine sperm banking; however, women are rarely presented with fertility preserving options.

Occupational exposures put nurses at risk of miscarriage

Occupational exposures put nurses at risk of miscarriage

Exposure to antineoplastic drugs and sterilizing agents are linked with a significantly increased risk of miscarriage.

EBCC: Pregnancy Does Not Promote Breast Cancer Relapse

EBCC: Pregnancy Does Not Promote Breast Cancer Relapse

Relapse rates are the same regardless of estrogen receptor status of tumor.

Counsel patients to explore fertility preservation

Interested patients should be referred to a reproductive endocrinologist as quickly as possible after a cancer diagnosis, as some fertility-preservation options require 2 to 3 weeks to complete.

Pregnancy, lactation, and cancer outcomes

Being diagnosed with cancer during pregnancy or while breastfeeding is not generally associated with increased risk of cancer-related death, researchers in Norway have found.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs